Myriad Genetics, Inc. (MYGN) shares outstanding
Myriad Genetics, Inc. (MYGN) had 92.60M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.2% higher than the 90.60M of fiscal 2024. Figures as of 18 Nov 2026, 12:36 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Shares outstanding, fiscal 2025
- 92.60M
- Change on fiscal 2024
- +2.2%
- Growth, 5 years
- +4.5% a year
- Growth, 10 years
- +2.2% a year
- Highest on record
- 99.15Mfiscal 2010
- Lowest on record
- 68.80Mfiscal 2017
- Fiscal years on record
- 182009–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Myriad Genetics, Inc. shares outstanding, in more detail
The market data feed counts 95.92M shares outstanding today.
Over the five fiscal years to 2025 the diluted share count grew at a compound 4.5% a year; over ten years the rate was 2.2% a year. Across the 18 fiscal years on record (2009–2025), the highest was 99.15M in fiscal 2010 and the lowest 68.80M in fiscal 2017.
Shares outstanding by fiscal year
Myriad Genetics, Inc. shares outstanding, year by year
| Fiscal year | Shares outstanding | Change | Year ended |
|---|---|---|---|
| 2025 | 92.60M | 2.2% up | |
| 2024 | 90.60M | 9.4% up | |
| 2023 | 82.80M | 2.7% up | |
| 2022 | 80.60M | 3.3% up | |
| 2021 | 78.00M | 4.3% up | |
| 2020 | 74.80M | — | |
| 2020 | 74.30M | 2.2% down | |
| 2019 | 76.00M | 5.6% up | |
| 2018 | 72.00M | 4.7% up | |
| 2017 | 68.80M | 6.3% down | |
| 2016 | 73.40M | 1.5% down | |
| 2015 | 74.50M | 4.7% down | |
| 2014 | 78.20M | 6.1% down | |
| 2013 | 83.30M | 3.7% down | |
| 2012 | 86.47M | 5.7% down | |
| 2011 | 91.70M | 7.5% down | |
| 2010 | 99.15M | 0.6% up | |
| 2009 | 98.57M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.
How to read it
A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.
Myriad Genetics, Inc., figure by figure
- Myriad Genetics, Inc. market cap
- Myriad Genetics, Inc. revenue
- Myriad Genetics, Inc. earnings
- Myriad Genetics, Inc. earnings per share (EPS)
- Myriad Genetics, Inc. P/E ratio
- Myriad Genetics, Inc. P/S ratio
- Myriad Genetics, Inc. P/B ratio
- Myriad Genetics, Inc. free cash flow
- Myriad Genetics, Inc. operating margin
- Myriad Genetics, Inc. dividend
- Myriad Genetics, Inc. total debt
- Myriad Genetics, Inc. cash on hand
- Myriad Genetics, Inc. total assets
- Myriad Genetics, Inc. return on equity (ROE)
- Myriad Genetics, Inc. return on invested capital (ROIC)
Myriad Genetics, Inc. (MYGN) overview: price, valuation and scorecard
Myriad Genetics, Inc. shares outstanding: questions and answers
How many shares does Myriad Genetics, Inc. have?
Myriad Genetics, Inc. (MYGN) had 92.60M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.2% higher than the 90.60M of fiscal 2024. The market data feed counts 95.92M shares outstanding today.
What is the growth rate of Myriad Genetics, Inc.'s diluted share count?
Over the five fiscal years to 2025 the diluted share count grew at a compound 4.5% a year; over ten years the rate was 2.2% a year.
What are the highest and lowest diluted share count figures on record for Myriad Genetics, Inc.?
Across the 18 fiscal years on record (2009–2025), the highest was 99.15M in fiscal 2010 and the lowest 68.80M in fiscal 2017.
How is Myriad Genetics, Inc.'s diluted share count calculated?
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Myriad Genetics, Inc. it is on record here for 18 fiscal years, 2009 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: shares outstanding
All stocks guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Myriad Genetics, Inc. (MYGN) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/MYGN/shares-outstanding
Underlying data: the company's filings with the SEC and Yahoo Finance.